Strategic development of CART therapies for the treatment of hematological and solid tumors (DESCARTHeS).
The DESCARTHeS project aims to develop key technology platforms for the present and future development of CAR-T cell-based anti-tumor therapies in Navarra.
The development of a specific CAR-T cell therapy for patients with acute myeloid leukemia (AML) or for patients with prostate cancer will be the main objective of this project. But at the same time, the development of this global project aims to establish a facilitating platform for the future development of new CAR-T for other hematological malignancies and gastrointestinal cancers.
- Start date: April 1, 2019
- End date: October 30, 2021
- Funder: Gobierno de Navarra. Proyectos estratégicos de I+D 2019
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.